Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis
- 1 October 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 37 (4) , 441-447
- https://doi.org/10.1016/s0168-8278(02)00214-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Current and novel immunosuppressive therapy for autoimmune hepatitisHepatology, 2002
- Ethnic differences in thiopurine methyltransferase pharmacogeneticsPharmacogenetics, 1999
- Thiopurine Methyltransferase Genotype and the Toxicity of Azathioprine in Japanese.Internal Medicine, 1999
- Genotypic and phenotypic analysis of the polymorphic thiopurine S‐methyltransferase gene (TPMT) in a European populationBritish Journal of Pharmacology, 1998
- Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.Journal of Clinical Investigation, 1998
- Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*Clinical Pharmacology & Therapeutics, 1997
- Azathioprine for Long-Term Maintenance of Remission in Autoimmune HepatitisNew England Journal of Medicine, 1995
- The clinical pharmacology of 6-mercaptopurineEuropean Journal of Clinical Pharmacology, 1992
- Human liver thiopurine methyltransferase pharmacogeneticsPharmacogenetics, 1992
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990